Download full announcement Demonstrates ability to predict early rejection in kidney transplant Supports successful development of a predictive blood test for transplant patients Renalytix AI plc (AIM: RENX), a developer... read more →
Download full announcement High quality production-scale batches of critical materials successfully produced Key milestone achieved for scaled commercial test production Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled... read more →
Download full announcement Renalytix AI plc(AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that the New York State Department of Health has issued a Clinical... read more →
Download full announcement Investigators now include transplant experts from University of Oxford, Yale School of Medicine, Emory University School of Medicine, Icahn School of Medicine at Mount Sinai, University of... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces a collaboration with University Medical Center Groningen (UMCG), Netherlands, to evaluate... read more →
Download full announcement Provides priority regulatory review of AI-enabled diagnostic for fast-progressing kidney disease Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces... read more →
Download full announcement NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or... read more →
Download full announcement RenalytixAI machine learning approach outperformed current standard of care in 1,369 patient study Renalytix AI plc(AIM: RENX), the developer of artificial intelligence-enabled diagnostics for kidney disease, announces... read more →
Download full announcement Renalytix AI plc (AIM: RENX), the AIM quoted developer of artificial intelligence-enabled diagnostics for kidney disease, announces its inaugural unaudited interim results for the six months ended... read more →
Download full announcement Investigators include leading transplant clinicians from Emory University, the University of Manitoba, the Westmead Hospital Sydney, and Icahn School of Medicine at Mount Sinai. Renalytix AI plc(LON:... read more →